HMOX2 and neoplasm: Enrichment analysis of the global protein expression data across all tumor samples showed that the heme degradation pathway enzymes BLVRA and HMOX2, as well as the mitogenic kinase RPS6KA1, among others, are significantly upregulated in EGFRm samples (Figure 6E).